Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients.

Autor: Kumar S; Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata 700091, Jadavpur, Kolkata, PIN 700032, India., Chatterjee M; Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata 700091, Jadavpur, Kolkata, PIN 700032, India., Ghosh P; Department of Economics, Bethune College, University of Calcutta, Kolkata, PIN 700006, India., Ganguly KK; Department of Microbiology, Michael Madhusudan Memorial College, Durgapur, PIN 713216, India., Basu M; Department of Microbiology, Dhruba Chand Halder College, University of Calcutta, Kolkata, PIN 743372, India., Ghosh MK; Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata 700091, Jadavpur, Kolkata, PIN 700032, India.

Publikováno v: Genes & diseases [Genes Dis] 2022 Aug 24; Vol. 10 (4), pp. 1318-1350. Date of Electronic Publication: 2022 Aug 24 (Print Publication: 2023).